Valuation: Avantor, Inc.

Market Cap 7.71B 6.74B 6.23B 5.75B 10.83B 740B 11.03B 74.26B 29.14B 363B 28.95B 28.31B 1,248B P/E 2026 *
30.5x
P/E 2027 * 26.2x
Enterprise Value 10.72B 9.37B 8.66B 8B 15.07B 1,030B 15.34B 103B 40.52B 504B 40.27B 39.38B 1,736B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.52x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 50 23/06/2026
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Date Insider Type Main position Quantity % Market Cap.
06-20Tax

Executive/Senior Manager

-3,010 0.0004%
05-07Buy

Director

10,000 0.0015%
05-06Free

Director

25,270 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%+10.69% - - 7.71B
+0.88%-6.87%-32.59%-17.16% 155B
+2.75%-1.55%-9.50%-6.89% 102B
+0.08%-2.35%+2.59%+57.32% 58.81B
-0.94%+5.94%+39.64%+55.35% 52.82B
+3.71%+3.61%-12.51%-39.21% 41.51B
+3.05%-1.85% - - 32.69B
+1.08%+0.71%-12.03%-45.74% 28.6B
-0.34%+0.72%+61.16%-7.14% 25.27B
+2.25%+1.29%-7.28%-7.08% 20.34B
Average +0.99%-1.85%+3.68%-1.32% 52.42B
Weighted average by Cap. +1.09%-4.09%-6.69%-0.67%

Financials

2026 *2027 *
Net sales 6.5B 5.68B 5.25B 4.85B 9.14B 624B 9.3B 62.62B 24.57B 306B 24.42B 23.88B 1,053B 6.64B 5.8B 5.36B 4.95B 9.33B 637B 9.5B 63.94B 25.09B 312B 24.93B 24.38B 1,075B
Net income 244M 213M 197M 182M 343M 23.42B 349M 2.35B 922M 11.47B 916M 896M 39.5B 289M 253M 233M 216M 406M 27.76B 414M 2.78B 1.09B 13.59B 1.09B 1.06B 46.81B
Net Debt 3.01B 2.63B 2.43B 2.25B 4.23B 289B 4.31B 29.02B 11.39B 142B 11.31B 11.06B 488B 2.36B 2.06B 1.91B 1.76B 3.32B 227B 3.38B 22.76B 8.93B 111B 8.87B 8.68B 383B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
15/07/26 US$11.43 +1.20% 1,019,130
14/07/26 US$11.29 +6.91% 13,327,956
13/07/26 US$10.56 +1.64% 6,526,503
10/07/26 US$10.39 -1.14% 6,654,980
09/07/26 US$10.51 +7.68% 9,119,663
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
11.29USD
Average target price
10.31USD
Spread / Average Target
-8.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock